Related Experiment Video
Updated: Aug 14, 2026

07:27
Robotics in Surgery: A Modular Robotic Platform Driven Gastric Wedge Resection
Published on: February 7, 2025
Retroperitoneal Renal Surgery with the Hugo™ RAS System: Feasibility, Setting and Perioperative Outcomes of the First
Andrea Iannuzzi1, Benito Fabio Mirto2, Fabio Machiella2
1Research Unit of Urology, Department of Medicine and Surgery, Università Campus Bio-Medico di Roma, 00128 Rome, Italy.
Journal of Clinical Medicine
|August 13, 2026
Summary
Retroperitoneal renal surgery using the Hugo™ RAS system is feasible and safe for partial nephrectomy and pyeloplasty. This study reports the first dedicated surgical series with standardized docking, demonstrating reproducible outcomes.
Area of Science:
- Urology
- Minimally Invasive Surgery
- Robotic Surgery
Background:
- Retroperitoneal renal surgery offers advantages but requires specialized techniques.
- The Hugo™ RAS system is a novel robotic platform for minimally invasive procedures.
Purpose of the Study:
- To evaluate the feasibility, safety, and reproducibility of retroperitoneal renal surgery using the Hugo™ RAS system.
- To describe the surgical setup, docking strategy, and perioperative outcomes for this specific application.
Main Methods:
- A series of 30 retroperitoneal renal surgeries (15 partial nephrectomies, 15 pyeloplasties) were performed using the Hugo™ RAS system.
- A standardized retroperitoneal access and a three-arm trocar configuration with predefined docking angles were employed.
- Feasibility was defined as successful completion without conversion to open or transperitoneal surgery; perioperative data were prospectively collected.
Main Results:
- All 30 procedures were completed successfully without conversion, demonstrating feasibility.
- Robot-assisted partial nephrectomy (RAPN) had a median docking time of 5 minutes and estimated blood loss of 200 mL, with 20% experiencing Clavien-Dindo grade II complications.
- Robot-assisted pyeloplasty had a median operative time of 150 minutes and estimated blood loss of 70 mL, with 7% experiencing a grade II complication. Renal function remained stable.
Conclusions:
- Retroperitoneal renal surgery with the Hugo™ RAS system is feasible, safe, and reproducible.
- A standardized docking and port configuration is crucial for successful outcomes.
- This approach offers a viable option for complex renal procedures.
